SABS EPS Estimates
SAB Biotherapeutics, Inc.
$2.55
+$0.05(+2.21%)
33
Overall
60
Value
18
Tech
21
Quality
Market Cap
$226.56M
Volume
474.79K
52W Range
$2.10 - $5.15
Target Price
$11.82
SABS EPS estimates: the consensus estimate for SAB Biotherapeutics, Inc.'s current fiscal year is -$1.17 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
SABS EPS Estimates
- EPS estimate, current quarter
- $-0.27
- EPS estimate, next quarter
- $-0.28
- EPS estimate, current year
- $-1.17
- EPS estimate, next year
- $-0.79
- EPS growth, 3-year
- +27.06%
| Fiscal year | EPS |
|---|---|
| 2025 | $0.22 |
| 2024 | $-3.68 |
| 2023 | $-7.64 |
| 2022 | $-4.30 |
| 2021 | $-6.30 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SABS | $2.55 | +2.2% | 474.79K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get SAB Biotherapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW